GYRE GYRE THERAPEUTICS INC Management Changes 8-K Filing 2024 - Appointment of Director Catalyst Biosciences, Inc. appointed David Epstein, Ph.D. as a director, and Rodney Nussbaum as chair of the Audit Committee.Get access to all SEC 8-K filings of the GYRE THERAPEUTICS INC